Full Press Release Details
Nautilus and our Platform
Nautilus Biotechnology
September 18, 2025
Nautilus Co-Founder and CEO Sujal Patel joined CFO Anna Mowry at the Q3 Investor Summit Group Virtual Conference to share why the world needs the Nautilus Platform to vastly improve drug development and usher in a new era of precision medicine. Watch the presentation to discover why we’re excited to redefine proteomics with a complete solution designed to confidently quantify the entire proteome and its myriad proteoforms with unbeatable reproducibility, accuracy, precision, and single-molecule sensitivity.
Watch the presentation
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Nautilus: Driving a revolution in proteomic analysis
New protein sequencing technology from Nautilus is unlocking the proteome and igniting a proteomics revolution.
Read more
A brief introduction to PrISM – The theoretical framework underpinning the Nautilus platform
Learn about Protein Identification by Short epitope Mapping (PrISM) - The theoretical framework underpinning the Nautilus Platform.
Read more
Nautilus: Driving a revolution in proteomic analysis (Part 2)
We give you an inside view on how cross-disciplinary thinking and collaboration will propel us into a proteomics-powered future.
Read more
Stay up-to-date on all things Nautilus